Lucid Diagnostics (LUCD) Other Working Capital Changes (2020 - 2026)
Lucid Diagnostics (LUCD) posted Other Working Capital Changes of $1.2 million for Q1 2026, up 574.05% on a QoQ basis from $185000.0 in Q1 2025, and up 574.05% year-over-year from $185000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 574.05% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 129.1% YoY) and the FY2025 annual result came in at $1.8 million, up 258.84% from the prior year.
- Other Working Capital Changes was $1.2 million for Q1 2026 at Lucid Diagnostics, up from $185000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.2 million in Q1 2026 and bottomed at -$168000.0 in Q1 2022.
- A 3-year average of $421333.3 and a median of $185000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 61.54% — and 2026, when it jumped 574.05%.
- Lucid Diagnostics' Other Working Capital Changes stood at -$168000.0 in 2022, then jumped by 210.12% to $185000.0 in 2025, then soared by 574.05% to $1.2 million in 2026.
- Business Quant data shows LUCD's Other Working Capital Changes at $1.2 million in Q1 2026, $185000.0 in Q1 2025, and -$168000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2025 | 185,000.00 |
| Mar 31, 2025 | 185,000.00 |
| Mar 31, 2025 | 185,000.00 |
| Mar 31, 2022 | -168,000.00 |
| Mar 31, 2022 | -168,000.00 |
| Mar 31, 2022 | -168,000.00 |
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Mar 31, 2021 | -104,000.00 |
| Mar 31, 2021 | -104,000.00 |
| Mar 31, 2021 | -104,000.00 |
| Dec 31, 2020 | 214,630.00 |
| Dec 31, 2020 | 214,630.00 |
| Dec 31, 2020 | 214,630.00 |